Categories: Health

California Gov. Newsom says the state is not going to do enterprise with Walgreens

California Gov. Gavin Newsom successfully defeated a recall attempt in California last year. When asked if he was preparing to run for president, Newsom insisted he wasn’t.

Justin Sullivan | Getty Images

California Gov. Gavin Newsom said Monday the state would no longer do business with him Walgreensafter the drugstore chain told 21 Republican attorneys general it would not sell the abortion pill in its states.

Newsom said on Twitter that the state was “done” with dealings with Walgreens. Brandon Richards, a spokesman for the governor, said California is reviewing all of Walgreens’ relationships with the state.

“We will not do business with companies that give in to right-wing bullies who are pushing their extremist agenda, or companies that prioritize politics over women’s and girls’ health,” Richards said.

According to a statement, Walgreens plans to sell mifepristone “in every jurisdiction where it is legally permitted to do so.” “Once we are FDA certified, we will be distributing this drug in accordance with federal and state laws,” the company added.

The Food and Drug Administration in January allowed retail pharmacies to sell the abortion pill mifepristone if they are certified under an agency program that oversees how the drug is used and distributed.

Walgreens plans to become certified to sell mifepristone where legal under state and federal law, the company said. In February, 21 Republican attorneys general warned Walgreens not to ship mifepristone in their states.

Join us for CNBC’s Healthy Returns on March 29, where we’re hosting a virtual gathering of healthcare CEOs, scientists, investors and innovators to reflect on the advances made today in reinventing the future of medicine. We also have an exclusive look at the best investment opportunities in biopharma, healthcare technology and managed care. Learn more and register today: http://bit.ly/3DUNbRo

The company told attorneys general it would not sell or ship the pill in their states. Politico first reported the news.

Mifepristone, used in combination with another drug called misoprostol, is the most common method of abortion in the United States, accounting for about half of all abortions.

CNBC Health & Science

Read CNBC’s latest global health coverage:

Mifepristone has become a central issue in the fight for access to abortion after the Supreme Court’s Roe v. Wade had picked up.

A group of anti-abortion doctors have petitioned a Texas federal court to stay the FDA’s approval of mifepristone. On the other hand, Democratic attorneys general have asked a federal court in Washington to declare the FDA’s remaining restrictions on mifepristone unconstitutional.

The FDA approved mifepristone more than two decades ago, but the agency has imposed restrictions to ensure the pill’s safe use. The agency has gradually eased these restrictions over the years as more evidence of their safety and effectiveness accumulates.

The agency removed the requirement for patients to receive the pill in person at certain health facilities and allowed the drugs to be mailed. Patients still need a prescription from a healthcare provider that is FDA certified.

Jimmy Page

MV Telegraph Writer Jimmy Page has been writing for all these 37 years.

Recent Posts

Eating places add protein, fiber for weight reduction drug customers

A mini burger, mini fries and mini beer, Clinton Hall's "Teeny Weeny Mini Meal", is…

1 day ago

Amanda Peet shares her breast most cancers analysis

After returning to Los Angeles, the Her Friends and Neighbors star shared children Frances19, Molly15,…

2 days ago

As Trump seems at Cuba, I bear in mind how various things was

Cuba suffered a widespread power outage on March 16, 2026, according to the national electric…

2 days ago

The UK authorities’s borrowing prices reached their highest degree since 2008

Lights shine on skyscrapers and commercial buildings across the skyline of the City of London,…

3 days ago

Uber and Rivian announce $1.25 billion deal for 50,000 robotaxis

The Rivian R2 is on display during the 2025 Los Angeles Auto Show at the…

4 days ago

Eli Lilly shares slide after bearish analyst name – this is our take

Shares of Eli Lilly fell 6% on Tuesday and are on track for their worst…

6 days ago

This website uses cookies.